Rare diseases
Investigational molecules
Locations
Wagistrasse 18, 8952
Neurimmune AG’s clinical research activity is centered on transthyretin amyloid cardiomyopathy (ATTR-CM), a progressive cardiac amyloidosis affecting adults. Its trial portfolio reflects interest in disease severity markers and the clinical management of this rare heart disease.
The sponsor’s research focus in this area aligns with the evaluation of therapeutic effects in amyloid-related cardiac dysfunction and the ongoing clinical assessment of patients with systemic amyloid disease.
Neurimmune AG runs clinical trials in conditions such as Cardiac amyloidosis, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
